A new NRF2 activator for the treatment of human metabolic dysfunction-associated fatty liver disease

por Hammoutene, Adel, Laouirem, Samira, Albuquerque, Miguel, Colnot, Nathalie, Brzustowski, Angélique, Valla, Dominique, Provost, Nicolas, Delerive, Philippe, Paradis, Valérie
Publicado 2023

Liver microRNA-21 is overexpressed in non-alcoholic steatohepatitis and contributes to the disease in experimental models by inhibiting PPARα expression

por Loyer, Xavier, Paradis, Valérie, Hénique, Carole, Vion, Anne-Clémence, Colnot, Nathalie, Guerin, Coralie L, Devue, Cécile, On, Sissi, Scetbun, Jérémy, Romain, Mélissa, Paul, Jean-Louis, Rothenberg, Marc E, Marcellin, Patrick, Durand, François, Bedossa, Pierre, Prip-Buus, Carina, Baugé, Eric, Staels, Bart, Boulanger, Chantal M, Tedgui, Alain, Rautou, Pierre-Emmanuel
Publicado 2016